In this article, let us take a look at the 5 Stocks With Double-Digit Returns. For a deeper discussion and an extended list, please see 10 Stocks With Double-Digit Returns.
Source: Pexels
5. Plug Power Inc. (NASDAQ:PLUG)
Plug Power recouped three days of losses on Monday, surging 15.83 percent to close at $3.22 apiece, as investors positioned portfolios in stocks benefitting from the artificial intelligence boom, while fleeing sectors seen as vulnerable to the uncertainties in the Middle East.
Additionally, Plug Power Inc. (NASDAQ:PLUG) is expected to announce the results of its earnings performance in the first quarter of the year, estimated to be between May 8 and 12, based on its historical earnings reporting dates.
Investors are expected to closely watch for the company’s outlook for the year under the leadership of newly-installed chief executive officer, Jose Luis Crespo, who assumed the role last March 2.
Prior to the CEO role, Crespo served as Plug Power Inc.’s (NASDAQ:PLUG) president and chief revenue officer, where he helped drive growth through cost discipline, margin expansion, and capital efficiency, resulting in revenues hitting more than $700 million last year from only $27 million in 2013.
He also deepened strategic partnerships with global customers, including Amazon, Walmart, Home Depot, Galp, and Iberdrola, while advancing hydrogen fuel cell and electrolyzer deployments across multiple industries.
Crespo replaced Andy Marsh, who transitioned to chairman of Plug Power Inc.’s (NASDAQ:PLUG) board of directors, consistent with the leadership transition plan announced last October.
4. Legend Biotech Corp. (NASDAQ:LEGN)
Legend Biotech soared for a 5th straight day on Monday, climbing 18.42 percent to close at $25.07 apiece, as investors took heart from two investment firms’ reiteration of bullish coverage for its stock.
In a market note, RBC Capital reaffirmed its “outperform” rating and $62 price target on shares of Legend Biotech Corp. (NASDAQ:LEGN), while HC Wainwright reiterated its “buy” recommendation and $50 price target.
RBC Capital said that its coverage reflected its optimism following Eli Lilly’s acquisition of Kelonia for $3.25 billion, which highlighted the growing interest in the CAR-T therapy market.
Kelonia is a biotechnology company focusing on the development of advanced cancer treatments. Both the latter and Legend Biotech Corp. (NASDAQ:LEGN) specialize in CAR-T therapy, a cutting-edge treatment that reprograms immune cells so those cells can find and kill cancer.
Meanwhile, HC Wainwright said that its coverage was based on its confidence in the in vivo CD19/CD20 CAR-T data, which is expected to be announced at the 2026 ASCO Annual Meeting in Chicago, Illinois, from May 29 to June 2, 2026.
Legend Biotech Corp. (NASDAQ:LEGN) signaled that a “major medical meeting” readout is imminent.
In other news, the firm announced dismal earnings performance last year, with net losses widening by 68 percent to $296.8 million from $177 million in 2024. Total revenues, however, surged by 64 percent to $1.029 billion from $627.3 million year-on-year.
3. MaxLinear Inc. (NASDAQ:MXL)
MaxLinear extended its winning streak to a 9th straight session on Monday, to hit an over two-year high, as investors resumed buying positions ahead of its earnings performance for the first quarter of the year, with revenues expected to grow by high double digits.
In intra-day trading, the stock climbed to its highest price of $33.13 before paring gains to finish the session just up by 20.78 percent at $31.73 apiece.
In a notice to investors, MaxLinear Inc. (NASDAQ:MXL) said that it would release its financial and operating highlights for the period after market close on Thursday, April 23. A conference call will be held to elaborate on the results.
For the said quarter, MaxLinear Inc. (NASDAQ:MXL) is expected to report a 35.5 percent to 46 percent growth in its revenues to a range of $130 million to $140 million, versus $95.9 million previously.
Gross margin is expected at 56 to 59 percent on a GAAP basis, and at a non-GAAP of 58 to 61 percent.
In other news, MaxLinear Inc. (NASDAQ:MXL) late last month announced a new addition to its industrial connectivity portfolio with the launch of the MxL8323x family of RS-485/RS-422 half-duplex transceivers.
The product was designed to deliver scalable data rates up to 50Mbps, robust ESD and EFT protection, and wide voltage compatibility for electrically harsh industrial applications.
2. Avis Budget Inc. (NASDAQ:CAR)
Avis Budget soared by 23.27 percent on Monday to finish at $608.80 apiece, amid another round of short squeeze.
The stock is a highly shorted company, with at least 20 percent of its float sold short, giving room for potential breakout rallies.
The rally came despite Barclays’ “sell” recommendation for its stock following the sharp short squeeze occurring over the past few weeks.
Barclays said that the rally was a “supply-demand mismatch” with two holders accounting for 71 percent of outright ownership, and over 100 percent of economic interest given outstanding swaps.
“All of this leads to uncertainty about how long this will last and whether CAR stock can go higher,” Barclays said.
Even with the improvements in the car fundamentals, Barclays said that the rally cannot be justified.
Year-to-date, Avis Budget Inc. (NASDAQ:CAR) has already gone up by 374 percent.
Last year, Avis Budget Inc. (NASDAQ:CAR) narrowed its net loss by 51 percent to $889 million from $1.82 billion in 2024. Revenues decreased by 1.6 percent to $11.6 billion from $11.79 billion year-on-year.
In the fourth quarter alone, Avis Budget Group Inc. (NASDAQ:CAR) incurred an attributable net loss of $747 million, or 61.8 percent lower than the $1.958 billion year-on-year. Revenues dipped 1.7 percent to $2.66 billion from $2.7 billion year-on-year.
1. Aevex Corp. (NYSE:AVEX)
Aevex soared even higher in its second day as a publicly listed company, as investor optimism continued to be fueled by the rosy prospects for the industry amid the ongoing geopolitical tensions.
At intra-day trading, Aevex Corp. (NYSE:AVEX)—a military drone-maker—climbed to as high as $42.34 before paring gains to end the session just up by 24.06 percent at $33.41 apiece.
From its initial public offering price of $20, its peak already represented a 111.7 percent growth in its stock.
The strong debut came on the heels of ongoing geopolitical tensions, which highlighted the need for stronger military defense products and services.
Aevex Corp. (NYSE:AVEX) successfully raised $320 million in fresh funds from the sale of 16 million shares to the public, valuing the company at $2.6 billion.
Proceeds from the offer, according to Aevex Corp. (NYSE:AVEX), will be used for the acquisition of 16 million shares in Athena Technology Solutions Holdings, LLC—a leading provider of full-spectrum airborne intelligence solutions for the global intelligence community.
While we acknowledge the potential of AVEX to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than AVEX and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge fund investor letters by entering your email below.
